在急性心力衰竭中前期的利尿药耐药性的流行率和特征:P-Value-AHF研究
Julia Baumberger1, Sabine Dinges1, Eleonora Lupi2
1Department of Internal Medicine, Stadtspital Zurich, Zurich, Switzerland.
ESC heart failure
|September 6, 2024
概括
在急性心力衰竭 (AHF) 患者中,前期利尿耐药性是罕见的,仅影响2.2%的患者. 早期,标准化循环利尿剂的使用是AHF有效解的关键.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 紧急医疗 紧急医疗
背景情况:
- 尿剂耐药性是治疗急性心力衰竭 (AHF) 的重要挑战,导致不充分的脱血.
- 建议对利尿反应进行早期评估,但对AHF前期耐药性的数据有限.
研究的目的:
- 确定急诊室 (ED) 患有AHF的患者中前期尿素耐药性的流行率和特征.
- 为了评估标准化循环利尿剂剂量方案的有效性.
主要方法:
- 在满足特定拥堵和NT-proBNP标准的ED中对AHF患者的潜在查.
- 基于先前的利尿剂使用,标准化的静脉循环利尿剂给药.
- 测量2小时的尿量和尿中的度,以确定前期的利尿抗性.
主要成果:
- 只有2.2% (93例中只有2例) 的患者符合预先抗利尿剂的标准.
- 耐药性患者患有较高的慢性/肝病,较低的血压,较高的肌和水平.
- 拥堵迹象,NT-proBNP和喷射分数在各组之间是相似的.
结论:
- 在未经选择的AHF患者呈现ED时,前期利尿耐药性并不常见.
- 循环利尿剂的标准化,协议化的方法对循环利尿剂的管理至关重要,以有效地减少AHF的堵塞.
- 先前存在的慢性病和肌氨酸升高与利尿剂耐药性有关.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers
322
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322
Antihypertensive Drugs: Action of Diuretics
634
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
634
Antihypertensive Drugs: Potassium-Sparing Diuretics
476
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
476


